Collectively, these studies provide a novel perspective towards developing a cancer treatment targeting mEAK-7-associated mTOR signaling in NSCLC and other malignancies exhibiting elevated mEAK-7 expression. Here, MTOR is linked to non-small cell lung carcinoma.